Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial intelligence in the drug discovery process.

With any new year, comes change, of course, and for Pharmaceutical Executive, we have an exciting one for our ... and sleeker look to the magazine, with a nod to some of those trusted business titles ...